fexofenadine has been researched along with Complications, Pregnancy in 2 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fexofenadine hydrochloride is a frequently used drug for treatment of allergic conditions during pregnancy, but the fetal safety of fexofenadine use has not been well studied." | 7.96 | Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes. ( Andersen, JT; Andersson, NW; Torp-Pedersen, C, 2020) |
| "Fexofenadine hydrochloride is a frequently used drug for treatment of allergic conditions during pregnancy, but the fetal safety of fexofenadine use has not been well studied." | 3.96 | Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes. ( Andersen, JT; Andersson, NW; Torp-Pedersen, C, 2020) |
| "Fexofenadine is a well-identified in vivo probe substrate of P-glycoprotein (P-gp) and/or organic anion transporting polypeptide (OATP)." | 1.62 | Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model. ( Bapat, P; Berger, H; de Carvalho Cavalli, R; de Lima Moreira, F; Koren, G; Lanchote, VL; Lubetsky, A; Pinto, L, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, NW | 1 |
| Torp-Pedersen, C | 1 |
| Andersen, JT | 1 |
| Pinto, L | 1 |
| Bapat, P | 1 |
| de Lima Moreira, F | 1 |
| Lubetsky, A | 1 |
| de Carvalho Cavalli, R | 1 |
| Berger, H | 1 |
| Lanchote, VL | 1 |
| Koren, G | 1 |
2 other studies available for fexofenadine and Complications, Pregnancy
| Article | Year |
|---|---|
Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes.
Topics: Adult; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Infant, Newborn; I | 2020 |
Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
Topics: Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Drug Interactions; Female; Fluoxeti | 2021 |